FOI 8182 - Patients treated with various drugs

Date: 13 June 2023 to 13 June 2026

How many patients have been treated with the following drugs in the past 4 months:

  • Erenumab (Aimovig) - any disease 
  • Eptinezumab (Vyepti) - any disease 
  • Fremanezumab (Ajovy) - any disease 
  • Galcanezumab (Emgality) - any disease 
  • Rimegepant (Vydura) - any disease 
  • Botulinum Toxin (i.e., Botox, Dysport, Xeomin) - migraine ONLY 
  • Request ID:
    FOI 8182
  • Category:
    Clinical - Drugs
  • Response:

    June 2023

    How many patients have been treated with the following drugs in the past 4 months: 

    • Erenumab (Aimovig) - any disease Nil
    • Eptinezumab (Vyepti) - any disease Nil
    • Fremanezumab (Ajovy) - any disease Nil
    • Galcanezumab (Emgality) - any disease Nil
    • Rimegepant (Vydura) - any disease Nil
    • Botulinum Toxin (i.e., Botox, Dysport, Xeomin) - migraine ONLY The Trust’s Pharmacy department does not record the indication for the use of the drug. Pharmacy can confirm they have issued Botulinum to 59 patients, for any indication.